A specialized integrin-binding motif enables proTGF-β2 activation by integrin αVβ6 but not αVβ8.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 06 2023
Historique:
medline: 8 6 2023
pubmed: 6 6 2023
entrez: 6 6 2023
Statut: ppublish

Résumé

Activation of latent transforming growth factor (TGF)-β2 is incompletely understood. Unlike TGF-β1 and β3, the TGF-β2 prodomain lacks a seven-residue RGDLXX (L/I) integrin-recognition motif and is thought not to be activated by integrins. Here, we report the surprising finding that TGF-β2 contains a related but divergent 13-residue integrin-recognition motif (YTSGDQKTIKSTR) that specializes it for activation by integrin αVβ6 but not αVβ8. Both classes of motifs compete for the same binding site in αVβ6. Multiple changes in the longer motif underlie its specificity. ProTGF-β2 structures define interesting differences from proTGF-β1 and the structural context for activation by αVβ6. Some integrin-independent activation is also seen for proTGF-β2 and even more so for proTGF-β3. Our findings have important implications for therapeutics to αVβ6 in clinical trials for fibrosis, in which inhibition of TGF-β2 activation has not been anticipated.

Identifiants

pubmed: 37279271
doi: 10.1073/pnas.2304874120
pmc: PMC10268255
doi:

Substances chimiques

integrin alphavbeta6 0
Transforming Growth Factor beta2 0
Integrins 0
Transforming Growth Factor beta1 0
Antigens, Neoplasm 0
Transforming Growth Factor beta 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2304874120

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM133893
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL159714
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM138396
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK124443
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007527
Pays : United States

Références

Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
pubmed: 17452350
Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):61-9
pubmed: 18094468
Nat Struct Mol Biol. 2018 Mar;25(3):289-296
pubmed: 29434346
Cell. 1999 Feb 5;96(3):319-28
pubmed: 10025398
Cold Spring Harb Perspect Biol. 2016 Jun 01;8(6):
pubmed: 27252363
Annu Rev Immunol. 2014;32:51-82
pubmed: 24313777
Cell Tissue Res. 2016 Sep;365(3):511-9
pubmed: 27139180
Dev Dyn. 2022 Jan;251(1):95-104
pubmed: 33742701
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13114-20
pubmed: 15277669
Cell. 2020 Feb 6;180(3):490-501.e16
pubmed: 31955848
PLoS One. 2011;6(4):e18556
pubmed: 21602908
J Cell Biol. 1989 Aug;109(2):863-75
pubmed: 2527241
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195692
Nature. 2011 Jun 15;474(7351):343-9
pubmed: 21677751
JCI Insight. 2019 Mar 26;5:
pubmed: 30913038
EMBO J. 1991 May;10(5):1091-101
pubmed: 2022183
Nat Struct Biol. 2001 May;8(5):412-6
pubmed: 11323715
Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1243-50
pubmed: 17001101
Sci Transl Med. 2021 Aug 4;13(605):
pubmed: 34349032
J Biol Chem. 2018 Feb 2;293(5):1579-1589
pubmed: 29109152
Science. 1992 Jul 17;257(5068):369-73
pubmed: 1631557
Mol Biol Cell. 2012 Mar;23(6):1129-39
pubmed: 22278742
Cancer Immunol Res. 2022 Apr 1;10(4):453-467
pubmed: 35181792
J Biol Chem. 2017 Nov 3;292(44):18091-18097
pubmed: 28912269
J Mol Biol. 2022 Mar 15;434(5):167439
pubmed: 34990654
J Cell Biol. 2004 Jun 7;165(5):723-34
pubmed: 15184403
J Cell Biol. 2007 Mar 12;176(6):787-93
pubmed: 17353357
Nat Commun. 2019 Dec 2;10(1):5481
pubmed: 31792290
FEBS Lett. 2002 Jan 30;511(1-3):65-8
pubmed: 11821050
MAbs. 2012 Nov-Dec;4(6):753-60
pubmed: 23778268
Sci Adv. 2021 May 7;7(19):
pubmed: 33962943
Nat Commun. 2016 Oct 10;7:13119
pubmed: 27721490
Hum Antibodies. 1997;8(1):3-16
pubmed: 9265500
J Biol Chem. 2009 Apr 24;284(17):11485-97
pubmed: 19240021
Toxicol Sci. 2023 Feb 17;191(2):400-413
pubmed: 36515490
J Cell Biol. 1996 May;133(4):921-8
pubmed: 8666675
Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12):
pubmed: 27638177
Mol Cell Biol. 2013 Nov;33(21):4334-45
pubmed: 24001772
J Cell Sci. 1995 Aug;108 ( Pt 8):2825-38
pubmed: 7593323
J Cell Physiol. 2005 Feb;202(2):361-70
pubmed: 15389580
EMBO J. 2017 Mar 1;36(5):629-645
pubmed: 28122868
JAMA. 2022 Oct 4;328(13):1291-1292
pubmed: 36170060
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Mol Biol. 1996 Dec 13;264(4):823-38
pubmed: 8980688
Development. 1997 Jul;124(13):2659-70
pubmed: 9217007
Nature. 2017 Feb 2;542(7639):55-59
pubmed: 28117447
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Cell Tissue Res. 2012 Jan;347(1):203-23
pubmed: 21953136
Int J Biochem Cell Biol. 2008;40(6-7):1068-78
pubmed: 18243766
J Immunol. 2010 Sep 15;185(6):3529-35
pubmed: 20720212
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
J Biol Chem. 2012 Jan 6;287(2):1043-53
pubmed: 22052913
J Biol Chem. 2002 Jun 14;277(24):21749-58
pubmed: 11932255
Elife. 2013 Sep 10;2:e01456
pubmed: 24040512
Cell. 2018 Jun 28;174(1):156-171.e16
pubmed: 29909984
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1128-1139
pubmed: 35771569
J Cell Biol. 2002 Apr 29;157(3):493-507
pubmed: 11970960
Am J Pathol. 2009 Oct;175(4):1362-70
pubmed: 19729474
Cold Spring Harb Perspect Biol. 2016 May 02;8(5):
pubmed: 27141051
J Cell Mol Med. 2005 Apr-Jun;9(2):421-37
pubmed: 15963261
Science. 2018 Nov 23;362(6417):952-956
pubmed: 30361387
J Biol Chem. 2004 Apr 23;279(17):17875-87
pubmed: 14960589
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Nat Struct Mol Biol. 2014 Dec;21(12):1091-6
pubmed: 25383667
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13419-24
pubmed: 12370423

Auteurs

Viet Q Le (VQ)

Program in Cellular and Molecular Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.

Bo Zhao (B)

Program in Cellular and Molecular Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.

Siddanth Ramesh (S)

Program in Cellular and Molecular Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115.

Cameron Toohey (C)

Program in Cellular and Molecular Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115.

Adam DeCosta (A)

Program in Cellular and Molecular Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115.

Julian Mintseris (J)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115.

Xinyue Liu (X)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115.

Steven Gygi (S)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115.

Timothy A Springer (TA)

Program in Cellular and Molecular Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH